Luteinizing hormone-releasing hormone agonist triptorelin antagonizes signal transduction and mitogenic activity of epidermal growth factor in human ovarian and endometrial cancer cell lines

International Journal of Oncology

Volumn 9, Issue 6, 1996, Pages 1129-1137

  Emons, Günter ^a   Müller, Volker ^a   Ortmann, Olaf ^a   Grossmann, Gereon ^a   Trautner, Ursula ^a   Stuckrad, Bettina V ^a   Schulz, Klaus Dieter ^a   Schally, Andrew V ^b  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

endometrial cancer; gonadotropin releasing hormone; luteinizing hormone releasing hormone; ovarian cancer; signal transduction

Indexed keywords

EPIDERMAL GROWTH FACTOR; GONADORELIN AGONIST; TRIPTORELIN;

ARTICLE; CONTROLLED STUDY; ENDOMETRIUM CARCINOMA; HUMAN; HUMAN CELL; MITOGENESIS; OVARY CARCINOMA; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

EID: 0029803245     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.9.6.1129     Document Type: Article

References (42)

1. Emons G, Ortmann O, Becker M, Irmer G, Springer B, Laun R, Hölzel F, Schulz KD and Schally AV: High affinity binding and direct antiproliferative effects of LHRH analogues in human ovarian cancer cell lines. Cancer Res 53: 5439-5446, 1993.
2. 6]-luteinizing hormone-releasing hormone and epidermal growth factor in human endometrial carcinoma. Cancer Res 50: 1841-1846, 1990.
3. Emons G, Schröder B, Ortmann O, Westphalen S, Schulz KD and Schally AV: High affinity binding and direct antiproliferative effects of luteinizing hormone-releasing hormone analogues in human endometrial cancer cell lines. J Clin Endocrinol Metab 77: 1458-1464, 1993.
4. Yano T, Pinski J, Radulovic S and Schally AV: Inhibition of human epithelial ovarian cancer cell growth in vitro by agonistic and antagonistic analogues of luteinizing hormone-releasing hormone. Proc Natl Acad Sci USA 91: 1701-1704, 1994.
5. Kakar SS, Grizzle WE and Neill JD: The nucleotide sequences of human GnRH receptors in breast and ovarian tumors are identical with that found in pituitary. Mol Cell Endocrinol 106: 145-149, 1994.
6. Imai A, Ohno T, Iida K, Fuseya T, Furui T and Tamaya T: Gonadotropin-releasing hormone receptor in gynecological tumors. Cancer 74: 2555-2561, 1994.
7. Irmer G, Bürger C, Müller R, Ortmann O, Peter U, Kakar SS, Neill JD, Schulz KD and Emons G: Expression of the messenger RNAs for luteinizing hormone-releasing hormone (LHRH) and its receptor in human ovarian epithelial carcinoma. Cancer Res 55: 817-822, 1995.
8. Ohno T, Imai A, Furui T, Takahaski K and Tamaya T: Presence of gonadotropin-releasing hormone and its messenger ribonucleic acid in human ovarian epithelial carcinoma. Am J Obstet Gynecol 169: 605-610, 1993.
9. Irmer G, Bürger C, Ortmann O, Schulz KD and Emons G: Expression of luteinizing hormone-releasing hormone and its mRNA in endometrial cancer cell lines. J Clin Endocrinol Metab 79: 916-919, 1994.
10. Emons G and Schally AV: The use of luteinizing hormone releasing hormone agonists and antagonists in gynecological cancers. Hum Reprod 9: 1364-1379, 1994.
11. Stojilkovic SS, Reinhardt J and Catt KJ: Gonadotropin-releasing hormone receptors: structure and signal transduction pathways. Endocrine Rev 15: 462-499, 1994.
12. Lee MT, Liebow C, Kramer AR and Schally AV: Effects of epidermal growth factor and analogues of luteinizing hormone-releasing hormone and somatostatin on phosphorylation and dephosphorylation of tyrosine residues of specific substrates in various tumors. Proc Natl Acad Sci USA 88: 1656-1660, 1991.
13. Liebow C, Lee MT, Kramer AR and Schally AV: Regulation of luteinizing hormone-releasing hormone receptor binding by heterologous receptor-stimulated tyrosine phosphorylation. Proc Natl Acad Sci USA 88: 2244-2248, 1991.
14. Marshall CJ: Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell 80: 179-185, 1995.
15. Hunter T: Protein kinases and phosphatases: the yin and yang of protein phosphorylation and signaling. Cell 80: 225-236, 1995.
16. Walton KM and Dixon JE: Protein tyrosine phosphatases. Annu Rev Biochem 62: 101-120, 1993.
17. Pan MG, Florio TF and Stork PJS: G-protein activation of a hormone-stimulated-phosphatase in human tumor cells. Science 256: 1215-1217, 1992.
18. Simon WE, Albrecht M, Hansel M, Dietel M and Hölzel F: Cell lines derived from human ovarian carcinomas: growth stimulation by gonadotropic and steroid hormones. J Natl Cancer Inst 70: 839-845, 1983.
19. Kunzmann R and Hölzel F: Karyotype alterations in human ovarian carcinoma cells during long-term cultivation and nude mouse passage. Cancer Genet Cytogenet 28: 102-112, 1987.
20. Kuramoto H, Tamura S and Notake Y: Establishment of a cell line of human endometrial adenocarcinoma in vitro. Am J Obstet Gynecol 114: 1012-1019, 1988.
21. Nishida M, Kasahara K, Kaneko M and Iwasaki H: Establishment of a new endometrial andenocarcinoma cell line, Ishikawa cells, containing estrogen and progesterone receptors. Acta Obstet Gynecol Jpn 37: 1103-1 111, 1985.
22. Cai RZ, Szöke B, Lu R, Fu D, Redding TW and Schally AV: Synthesis and biological activity of highly potent octapeptide analogs of somatostatin. Proc Natl Acad Sci USA 83: 1896-1900, 1986.
23. Berridge MJ, Downes CP and Hanley MR: Lithium amplifies agonist-dependent phosphatidylinositol responses in brain and salivary glands. Biochem J 206: 587-595, 1982.
24. Emons G, Frevert EU, Ortmann O, Fingscheidt U, Sturm R, Kiesel L and Knuppen R: Studies on the subcellular mechanisms mediating the negative estradiol effect on GnRH-induced LH-release by rat pituitary cells in culture. Acta Endocrinol 121: 350-360, 1989.
25. Ortmann O, Bakhit M, Bloh P, Schulz K-D and Emons G: Ovarian steroids modulate gonadotropin-releasing hormone-induced biphasic luteinizing hormone secretory responses and inositol phosphate accumulation in rat anterior pituitary cells and αT3-1 gonadotrophs. J Steroid Biochem Mol Biol 54: 101-109, 1995.
26. Hirota K, Hirota T, Aguilera G and Catt KJ: Hormone-induced redistribution of calcium-activated, phospholipid-dependent protein kinase in pituitary gonadotrophs. J Biol Chem 260: 3243-3246, 1985.
27. Thomas TP, Gopalakrishna R and Anderson WB: Hormone-and tumor promotor-induced activation or membrane association of protein kinase C in intact cells. Meth Enzymol 141: 399-411, 1987.
28. Horn F, Bilezikjian LM, Perrin MH, Bosma MM, Windle JJ, Huber KS, Blount AL, Hille B, Vale W and Mellon PM: Intracellular responses to gonadotropin-releasing hormone in a clonal cell line of the gonadotrope lineage. Mol Endocrinol 5: 347-355, 1991.
29. Todaro GJ, Fryling C and De Larco JE: Transforming growth factors produced by certain human tumor cells: polypeptides that interact with epidermal growth factor receptors. Proc Natl Acad Sci USA 77: 5258-5262, 1980.
30. Clayton RN, Shakespear RA, Duncan JA and Marshall JC: (with appendix by Munson PJ and Rodbard D): Radioiodinated nondegradable gonadotropin releasing hormone analogs: new probes for the investigation of pituitary gonadotropin releasing hormone receptors. Endocrinology 105: 1369-1376, 1979.
31. Donato NJ, Gallick GE, Steck PA and Rosenblum MG: Tumor necrosis factor modulates epidermal growth factor receptor phosphorylation and kinase activity in human tumor cells. J Biol Chem 264: 20474-20481, 1989.
32. Tonks NK, Diltz CD and Fischer EH: Purification of protein-tyrosine phosphatases from human placenta. Meth Enzymol 201: 427-442, 1991.
33. Wu J, Dent P, Jelinek T, Wolfman A, Weber MJ and Sturgill TW: Inhibition of the EGF-activated MAP kinase signaling pathway by adenosine 3′,5′-monophosphate. Science 262: 1065-1069, 1993.
34. Clark-Lewis I, Sanghera JS and Peleck SL: Definition of a consensus sequence for peptide substrate recognition by p44mpk, the meiosis-activated myelin basic protein kinase. J Biol Chem 266: 15180-15184, 1991.
35. Kleinman P, Roberts CT, Le Roith D, Schally AV, Levy J and Sharoni Y: Regulation of endometrial cancer growth by insulin like growth factors and the luteinizing-hormone releasing hormone antagonist SB-75. Regul Pept 48: 91-98, 1993.
36. Imai A, Ohno T, Furui F, Takahashi K, Matsuda T and Tamaya T: Gonadotropin releasing hormone stimulates phospholipase C but not protein phosphorylation/dephosphorylation in plasma membrane from human epithelial ovarian cancer. Int J Gynecol Cancer 3: 311-317, 1993.
37. Takagi H, Imai A, Furui T, Horibe S, Fuseya T and Tamaya T: Evidence for tight coupling of gonadotropin-releasing hormone receptors to phosphatidylinositol kinase in plasma membrane from ovarian carcinomas. Gynecol Oncol 58: 110-115, 1995.
38. Imai A, Takagi H, Furui T, Horibe S, Fuseya T and Tamaya T: Evidence for coupling of phosphotyrosine phosphatase to gonadotropin-releasing hormone receptor in ovarian carcinoma membrane. Cancer 77: 132-137, 1996.
39. Yano T, Pinski J, Halmos G, Szepeshazy K, Groot K and Schally AV: Inhibition of growth of OV-1063 human epithelial ovarian cancer xenografts in nude mice by treatment with luteinizing hormone-releasing hormone antagonist SB-75. Proc Natl Acad Sci USA 91: 7090-7094, 1994.
40. NIH consensus development panel on ovarian cancer. NIH consensus conference: ovarian cancer. Screening, treatment, and follow-up. JAMA 273: 491-497, 1995.
41. Godwin AK, Perez RP, Johnson SW, Hamaguchi K and Hamilton TC: Growth regulation of ovarian cancer. Hematol Oncol Clin N Amer 6: 829-841, 1992.
42. Murphy LJ: Growth factors and steroid hormone action in endometrial cancer. J Steroid Biochem Mol Biol 48: 419-423, 1994.